Theranostics 2014; 4(11):1085-1095. doi:10.7150/thno.9933

Research Paper

Enhancing Therapeutic Effects of Docetaxel-Loaded Dendritic Copolymer Nanoparticles by Co-Treatment with Autophagy Inhibitor on Breast Cancer

Xudong Zhang1,2,*, Ying Yang1,2,*, Xin Liang3, Xiaowei Zeng1,2, Zhigang Liu4, Wei Tao1,2, Xiaojun Xiao4, Hongbo Chen1,2, Laiqiang Huang 1,2✉, Lin Mei1, 2✉

1. School of Life Sciences, Tsinghua University, Beijing 100084, P.R. China;
2. The Shenzhen Key Lab of Gene and Antibody Therapy, Division of Life and Health Sciences, Graduate School at Shenzhen, Tsinghua University, Shenzhen 518055, P.R. China;
3. Key Laboratory of Regenerative Biology, South China Institute for Stem Cell Biology and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, University of Chinese Academy of Sciences, Guangzhou, Guangdong, 510530, P.R. China;
4. Institute of Allergy and Immunology, School of Medicine, Shenzhen University, Shenzhen 518060, P.R. China.
* These authors contributed equally to this work.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.
Citation:
Zhang X, Yang Y, Liang X, Zeng X, Liu Z, Tao W, Xiao X, Chen H, Huang L, Mei L. Enhancing Therapeutic Effects of Docetaxel-Loaded Dendritic Copolymer Nanoparticles by Co-Treatment with Autophagy Inhibitor on Breast Cancer. Theranostics 2014; 4(11):1085-1095. doi:10.7150/thno.9933. Available from https://www.thno.org/v04p1085.htm

File import instruction

Abstract

Dendrimers are synthetic nanocarriers that comprise a highly branched spherical polymer as new, efficient tools for drug delivery. However, the fate of nanocarriers after being internalized into cells has seldom been studied. Docetaxel loaded dendritic copolymer H40-poly(D,L-lactide) nanoparticles, referred to as “DTX-H40-PLA NPs”, were prepared and used as a model to evaluate whether the NPs were sequestered by autophagy and fused with lysosomes. Besides being degraded through the endolysosomal pathway, the DTX-loaded H40-PLA NPs were also sequestered by autophagosomes and degraded through the autolysosomal pathway. DTX-loaded H40-PLA NPs may stop exerting beneficial effects after inducing autophagy of human MCF-7 cancer cells. Co-delivery of autophagy inhibitor such as chloroquine and chemotherapeutic drug DTX by dendritic copolymer NPs greatly enhanced cancer cell killing in vitro, and decreased both the volume and weight of the tumors in severe combined immunodeficient mice. These findings provide valuable evidence for development of nanomedicine such as dendritic copolymer NPs for clinical application.

Keywords: Nanomedicine, Endocytosis, Autophagy, Docetaxel, Chloroquine, Dendrimers.